Evaluation Of The Safety And Efficacy Of An Oral Molecularly-Targeted Therapy, STI-571, In Patients (PTS) With Unresectable Or Metastatic Gastrointestinal Stromal Tumors (GISTS) Expressing C-KIT (CD117)

Diana Stripp, MD

University of Pennsylvania Cancer
Ultima Vez Modificado: 14 de mayo del 2001

Translation for this article does not exist


Cancer and Hair Loss
by Bob Riter
February 11, 2016